• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镓- DOTATATE正电子发射断层扫描/计算机断层扫描用于检测磷尿性间叶肿瘤诱导的骨软化症的复发。

Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia.

作者信息

Bhalla Manav I, Wirtz Kennedy M, Fair Eric S, Bucklan Daniel J

机构信息

Department of Radiology, Froedtert Hospital and The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

出版信息

World J Nucl Med. 2019 Jul 23;19(1):78-81. doi: 10.4103/wjnm.WJNM_92_18. eCollection 2020 Jan-Mar.

DOI:10.4103/wjnm.WJNM_92_18
PMID:32190030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7067133/
Abstract

Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) has shown superiority over Indium-octreotide scanning for the detection of phosphaturic mesenchymal tumors (PMTs). We report a case of tumor-induced osteomalacia resulting from PMT which, although initially clinically suspected, was not localized on octreotide scintigraphy performed several years prior. Subsequent surgical excision of a presumed benign osseous lesion a few years later revealed the diagnosis on pathology. Imaging assessment using Ga-DOTATATE PET/CT following recent clinical suspicion for recurrence revealed an intense tracer-avid lesion at the primary tumor site. DOTATATE imaging plays an important role in localizing tumors with high somatostatin receptor expression, such as neuroendocrine tumors (pheochromocytoma, paraganglioma, and neuroblastoma), meningioma, and mesenchymal tumors, causing oncogenic osteomalacia.

摘要

镓标记的生长抑素类似物正电子发射断层扫描/计算机断层扫描(PET/CT)在检测磷酸尿性间叶肿瘤(PMT)方面已显示出优于铟标记的奥曲肽扫描。我们报告一例由PMT引起的肿瘤性骨软化症病例,尽管最初临床上怀疑有该疾病,但在数年前进行的奥曲肽闪烁扫描中未发现其定位。几年后对一个推测为良性的骨病变进行手术切除,术后病理检查明确了诊断。最近临床怀疑复发后,使用镓标记的生长抑素类似物PET/CT进行影像学评估,结果显示在原发肿瘤部位有一个摄取示踪剂强烈的病变。生长抑素类似物成像在定位具有高生长抑素受体表达的肿瘤方面发挥着重要作用,这些肿瘤包括神经内分泌肿瘤(嗜铬细胞瘤、副神经节瘤和神经母细胞瘤)、脑膜瘤以及导致肿瘤性骨软化症的间叶肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/c6dcee9e5f22/WJNM-19-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/e50759d8c63d/WJNM-19-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/71b9cebe0482/WJNM-19-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/9657c9018643/WJNM-19-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/c6dcee9e5f22/WJNM-19-78-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/e50759d8c63d/WJNM-19-78-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/71b9cebe0482/WJNM-19-78-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/9657c9018643/WJNM-19-78-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf2/7067133/c6dcee9e5f22/WJNM-19-78-g004.jpg

相似文献

1
Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia.镓- DOTATATE正电子发射断层扫描/计算机断层扫描用于检测磷尿性间叶肿瘤诱导的骨软化症的复发。
World J Nucl Med. 2019 Jul 23;19(1):78-81. doi: 10.4103/wjnm.WJNM_92_18. eCollection 2020 Jan-Mar.
2
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
3
177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors.177Lu-DOTATATE肽受体放射性核素治疗复发性导致骨软化症的颅底磷酸尿性间叶肿瘤:肽受体放射性核素治疗在神经内分泌肿瘤之外的潜在应用
J Nucl Med Technol. 2016 Dec;44(4):248-250. doi: 10.2967/jnmt.116.177873. Epub 2016 Sep 15.
4
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
5
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.18F-FDG 和 68Ga-DOTATATE PET/CT 对肿瘤致成瘤性骨软化症定位的比较。
Clin Nucl Med. 2015 Jan;40(1):e6-e10. doi: 10.1097/RLU.0000000000000460.
6
Phosphaturic mesenchymal tumor demonstrated by Ga-DOTATATE PET/CT in a patient: a case report.1例患者经镓- DOTATATE PET/CT检查发现的促尿磷排泄间叶肿瘤:病例报告
EJNMMI Rep. 2024 Sep 18;8(1):30. doi: 10.1186/s41824-024-00219-3.
7
68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.68Ga-DOTATATE PET/CT、99mTc-HYNIC-奥曲肽SPECT/CT及全身磁共振成像在神经内分泌肿瘤检测中的应用:一项前瞻性试验
J Nucl Med. 2014 Oct;55(10):1598-604. doi: 10.2967/jnumed.114.144543. Epub 2014 Aug 28.
8
The value of somatostatin receptor imaging with In-111 Octreotide and/or Ga-68 DOTATATE in localizing Ectopic ACTH producing tumors.使用铟 - 111奥曲肽和/或镓 - 68 DOTATATE进行生长抑素受体显像在定位异位促肾上腺皮质激素分泌肿瘤中的价值。
Mol Imaging Radionucl Ther. 2013 Aug;22(2):49-55. doi: 10.4274/Mirt.69775. Epub 2013 Aug 1.
9
Ga-68 DOTATATE Positron Emission Tomography-Computed Tomography Imaging in Oncogenic Osteomalacia: Experience from a Tertiary Level Hospital in South India.镓-68 DOTATATE正电子发射断层扫描-计算机断层扫描成像在肿瘤性骨软化症中的应用:来自印度南部一家三级医院的经验。
Indian J Nucl Med. 2019 Jul-Sep;34(3):188-193. doi: 10.4103/ijnm.IJNM_14_19.
10
Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.奥曲肽受体显像在非(131)I 摄取的转移性分化型甲状腺癌中评估(177)Lu-DOTATATE 肽受体放射性核素治疗的可行性:适合肽受体放射性核素治疗的患者比例较低,且存在嗜铬粒蛋白 A 水平阳性神经内分泌分化的证据。
Clin Nucl Med. 2014 Jun;39(6):505-10. doi: 10.1097/RLU.0000000000000429.

引用本文的文献

1
Clinical features and treatment of hypophosphatemia and associated complications induced by Phosphaturic mesenchymal tumors: A case series of six patients.磷尿性间叶肿瘤所致低磷血症及其相关并发症的临床特征与治疗:6例病例系列报告
Bone Rep. 2024 Dec 31;24:101822. doi: 10.1016/j.bonr.2024.101822. eCollection 2025 Mar.
2
Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.肿瘤性骨软化症中的持续性和复发性:文献系统综述及全国调查/病例系列研究结果。
Endocrine. 2022 Jun;76(3):709-721. doi: 10.1007/s12020-022-03039-2. Epub 2022 Apr 5.

本文引用的文献

1
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
2
Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models.177镥标记的生长抑素受体激动剂和拮抗剂在临床前模型中治疗反应的比较
J Nucl Med. 2016 Feb;57(2):260-5. doi: 10.2967/jnumed.115.167007. Epub 2015 Oct 29.
3
Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation.
68Ga-DOTATATE PET/CT 进行生长抑素受体显像:临床应用、正常表现、解读要点及陷阱。
Radiographics. 2015 Mar-Apr;35(2):500-16. doi: 10.1148/rg.352140164.
4
68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.68Ga DOTA-TATE PET/CT能够在肿瘤诱导的骨软化症患者中定位肿瘤,而这些患者的111In-奥曲肽SPECT/CT检查结果为阴性。
Bone. 2014 Jul;64:222-7. doi: 10.1016/j.bone.2014.04.016. Epub 2014 Apr 24.
5
Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET/CT vs somatostatin receptor-based functional scans: a series of nine patients.原发性肿瘤所致骨软化症的功能成像:FDG PET/CT 与基于生长抑素受体的功能扫描的相对性能:一系列 9 例患者。
Clin Endocrinol (Oxf). 2014 Jul;81(1):31-7. doi: 10.1111/cen.12426. Epub 2014 Mar 12.
6
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
JAMA. 2005 Sep 14;294(10):1260-7. doi: 10.1001/jama.294.10.1260.
7
68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.68Ga-DOTANOC:一种对生长抑素受体亚型2和5具有高亲和力的用于正电子发射断层显像(PET)成像的首个化合物。
Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):724. doi: 10.1007/s00259-004-1697-4.
8
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.大多数骨软化症相关的间充质肿瘤是单一组织病理学实体:32例分析及文献综述
Am J Surg Pathol. 2004 Jan;28(1):1-30. doi: 10.1097/00000478-200401000-00001.
9
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.成骨细胞骨软化症和X连锁低磷血症中的成纤维细胞生长因子23
N Engl J Med. 2003 Apr 24;348(17):1656-63. doi: 10.1056/NEJMoa020881.
10
Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report.
Clin Nucl Med. 2002 Aug;27(8):582-3. doi: 10.1097/00003072-200208000-00007.